Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

PMS-BUSULFAN 6 MG

BUSULFAN : 6 MG · DIN 02477343 · PHARMASCIENCE INC

Health Canada status: MARKETED

What is PMS-BUSULFAN?

PMS-BUSULFAN 6 MG contains BUSULFAN : 6 MG. It is listed in the Health Canada Drug Product Database under DIN 02477343, held by PHARMASCIENCE INC, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 29-Mar-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is PMS-BUSULFAN used for?

pms-BUSULFAN (busulfan) injection is indicated for use in combination with other chemotherapeutic agents and/or radiotherapy as a conditioning regimen prior to hematopoietic progenitor cell transplantation, including: acute lymphocytic leukemia, acute non-lymphocytic leukemia, acute myeloid leukemia, chronic myeloid leukemia, non-Hodgkin’s lymphoma, Hodgkin’s disease, multiple myeloma, and myelodysplastic syndrome.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02477343
Brand namePMS-BUSULFAN
Generic / active ingredientBUSULFAN : 6 MG
ManufacturerPHARMASCIENCE INC
Strength6 MG
Dosage formSOLUTION
Route of administrationINTRAVENOUS
SchedulePrescription
ATC codeL01AB01 BUSULFAN
AHFS class10:00.00
BiosimilarNo
Health Canada statusMARKETED
Status date29-Mar-2019
Original market date2019-03-29 00:00:00

How is it stored and handled?

null

How is it supplied?

null

What can be used instead?

Other Canadian products sharing ATC code L01AB01 BUSULFAN. 3 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
BUSULFAN FOR INJECTION60 MG / 10 MLSOLUTIONSTERIMAX INCMARKETEDDIN 02463733
MYLERAN2 MGTABLETASPEN PHARMACARE CANADA INC.MARKETEDDIN 00004618
BUSULFAN FOR INJECTION60 MG / 10 MLSOLUTIONAURO PHARMA INCAPPROVEDDIN 02521296
BUSULFAN FOR INJECTION60 MG / 10 MLSOLUTIONEUGIA PHARMA INC.APPROVEDDIN 02536935
BUSULFAN FOR INJECTION60 MG / 10 MLSOLUTIONMARCAN PHARMACEUTICALS INCAPPROVEDDIN 02475006
BUSULFAN INJECTION60 MG / 10 MLSOLUTIONAPOTEX INCAPPROVEDDIN 02473127
BUSULFEX60 MG / 10 MLSOLUTIONOTSUKA PHARMACEUTICAL CO LTDCANCELLED POST MARKETDIN 02240602

Who else supplies BUSULFAN worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. BUSULFAN appears in 17 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for PMS-BUSULFAN

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for PMS-BUSULFAN

Health Canada Drug Product Database (DPD), DIN 02477343. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.